bioRxivBiophysics
Zinc Determines Dynamical Properties and Aggregation Kinetics of Human Insulin
K. Pounot, G. W. Grime, A. Longo, M. Zamponi, D. Noferini, V. Cristiglio, T. Seydel, E. F. Garman, M. Weik, V. Fodera, G. Schiro
Abstract
Protein aggregation is a widespread process leading to deleterious consequences in the organism, with amyloid aggregates being important not only in biology but also for drug design and biomaterial production. Insulin is a protein largely used in diabetes treatment and its amyloid aggregation is at the basis of the so-called insulin-derived amyloidosis. Here we uncover the major role of zinc in both insulin dynamics and aggregation kinetics at low pH, where the formation of different amyloid superstructures (fibrils and spherulites) can be thermally induced. Amyloid aggregation is accompanied by zinc release and the suppression of water-sustained insulin dynamics, as shown by particle-induced X-ray emission and X-ray absorption spectroscopy and by neutron spectroscopy, respectively. Our study shows that zinc binding stabilizes the native form of insulin by facilitating hydration of this hydrophobic protein and suggests that introducing new binding sites for zinc can improve insulin stability and tune its aggregation propensity.Statement of Significance Localized amyloidosis occurs at insulin injection sites for diabetes treatment, leading to deleterious inflammations known as insulin-derived amyloidosis. Amyloid superstructures are also promising candidates in the field of biomaterials. Here we revealed that zinc, coordinated to insulin in the native form, is released upon amyloid aggregation, when insulin forms superstructures known as fibrils and spherulites. Zinc release leads to a full suppression of functionally essential protein dynamics through a modification of the protein’s hydration properties and completely modifies insulin amyloid kinetics. The results suggest that changes in protein hydration upon zinc binding/release modifies both stability and dynamics of insulin and might then be a general strategy to control protein stability and tune protein aggregation into amorphous and ordered superstructures.View Full Text
- organism: human
- assay: proteomics
- research focus: protein folding & dynamics
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Polysorbate 80 Controls Morphology, Structure and Stability of Human Insulin Amyloid-Like Spherulites
X. Zhou, D. F. Galparsoro, … V. Fodera·bioRxiv·Aug 10, 2021
- Insulin Amyloid Morphology is Encoded in H-bonds and Electrostatics Interactions Ruling Protein Phase Separation
S. J. Lenton, H. Chaaban, … V. Fodera·bioRxiv·Jan 10, 2024
- Formulation excipients and their role in insulin stability and association state in formulation
C. L. Maikawa, L. T. Nguyen, … E. A. Appel·bioRxiv·Aug 1, 2022
- Anionic lipid catalyzes the generation of cytotoxic insulin oligomers
Jhinuk Saha, Audrey Wolszczak, … Ayyalusamy Ramamoorthy·BiomoleculesPeer-reviewed·Jul 11, 2025
- High resolution structure of a partially folded insulin aggregation intermediate
B. N. Ratha, R. K. Kar, … A. Bhunia·bioRxiv·Jul 28, 2019
- FAIM Inhibits Insulin Amyloidogenesis through a Noncanonical Aggregation Pathway
Dana Wolfe, Jhinuk Saha, … Ayyalusamy Ramamoorthy·bioRxiv·Jul 14, 2026